Molecular Diagnostics

Blood Test Can Predict How Patient’s Cancer Could Grow and Spread
Researchers have demonstrated how cancer cells' DNA changes can help anticipate their future behavior, paving the way for the development of blood tests to predict cancer growth and spread, track it, and quickly adapt treatment in real-time. More...14 Apr 2023

First and Only Clinically Validated Circulating TTMV DNA Blood Test Detects HPV-Driven Cancer
An innovative and accessible blood test can potentially enhance patient outcomes by allowing doctors to choose the most appropriate treatment options for each patient, aiming to improve results while minimizing side effects and treatment-related morbidity. More...13 Apr 2023

First-of-Its-Kind Study Establishes Pediatric Reference Intervals for Common Cardiovascular Disease Tests
A groundbreaking study has now defined pediatric reference intervals for these two common cardiovascular disease tests, which is vital for improving heart condition diagnosis and treatment in children. More...13 Apr 2023

World’s Most Comprehensive Whole Genome Sequencing Solution Diagnoses Rare and Neurodegenerative Diseases
The world’s most comprehensive whole genome sequencing solution for rare and neurodegenerative diseases integrates state-of-the-art technology and an efficient CE-IVD bioinformatics pipeline with a vast biodatabank of around 700,000 patients from over 120 diverse countries. More...13 Apr 2023


Genomic Testing to Help Better Assess and Treat Heart Disease Patients
Cardiovascular disease is the primary cause of death worldwide, with genetics playing a crucial role in determining a patient's risk and response to common medications. A series of clinical studies will now evaluate the effects of comprehensive genomic testing in various disease areas. More...12 Apr 2023
In Other News
Next-Generation Diagnostic Test Predicts Drug Responses to Enable More Precise Cancer Therapy
Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care
New Blood Test Identifies Type 2 Diabetes Risk by Analyzing DNA Changes
Breast Cancer Subtyping Assay on Rapid MDx Platform to Deliver Fastest Time to Results
Blood-Based Biomarkers Detectable by Simple Blood Test Could Simplify Diagnosis of Alzheimer's
Benchtop Automated ELISA Platform Achieves Consistent Biomarker Detection
Next-Gen IVD LC-MS/MS System 5X More Sensitive for Quantifying Analytes in Saliva, Breath and Dried Blood Spots
Easy-to-Administer Blood Test Could Enable High-Risk Lung Cancer Screening
Real-Time Quick-Response PCR Test Marks First Real Innovation in Subtyping Breast Cancer in Decades
Testing for Biomarkers in Urine and Blood Can Predict Patient’s Risk of Developing Chronic Kidney Disease
Non-Invasive Diagnostic Test Improves Detection of Oral Cancer
Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets
New Integrated PCR Solutions Offer Flexibility and Portability for Small Laboratories and On-Site Testing
Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment
Blood Test for Multiple Pathways Related to Alzheimer’s Could Enable Earlier and Less-Invasive Diagnosis
POC Test Detects Genetic Blood Disorders with High Accuracy
Non-Invasive Fecal DNA Test Accurately Detects Colorectal Cancer and Precancerous Lesions
Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office
Serum Protein Test Can Predict Outcomes for Liver Failure Patients
Fully Automated Blood-Based Assays Measure Biomarker for Neurodegenerative Diseases within 35 Minutes
POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds
Transformative NGS Innovation Expands Access to Genomic Testing for Tuberculosis Patients
Quick, Affordable Finger-Prick Test Diagnoses Common STI in Five Minutes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








